≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Carcinoma in situ of breast

Endpoint Browser PheWeb

CD2_INSITU_BREAST_EXALLC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

only females

-

2. Check conditions

  • not C3_BREAST
-

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D05
  • Cause of death: ICD-10 — D05
  • Cancer registry: Topography ICD-O-3 — C50
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 2

3 out of 7 registries used, show all original rules.

-

4. Check minimum number of events

None

-

5. Include endpoints

-

6. Filter based on genotype QC (FinnGen only)

None

-

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
2
First used in FinnGen datafreeze
DF9
Parent code in ICD-10
D00-D09
Name in latin
Carcinoma in situ vulvae

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 7107 7107 -
Only index persons 6938 6938 -
Unadjusted period prevalence (%)
Whole population 0.20 0.20 -
Only index persons 0.26 0.26 -
Median age at first event (years)
Whole population - 60.20 -
Only index persons - 60.15 -

-FinnGen-

Key figures

All Female Male
Number of individuals 166 166 -
Unadjusted period prevalence (%) 0.06 0.06 -
Median age at first event (years) 60.25 60.25 -

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
124
Matched controls
1240
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
+∞
121.8
96
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
49.3
44
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
33.9
31
*
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
115.6
32.6
34
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
357.8
29.0
28
*
HAB99
NOMESCO Finland
Other partial excision of mammary gland
56.9
23.5
27
6
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
+∞
20.4
19
*
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
125.2
20.2
21
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
18.2
17
*
D05.0
ICD-10 Finland
Lobular carcinoma in situ
+∞
18.2
17
*
D05.9
ICD-10 Finland
Carcinoma in situ of breast, unspecified
+∞
17.1
16
*
WX402
NOMESCO Finland
General anaesthesia
7.0
16.1
44
90
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
16.0
15
*
HA1AA
NOMESCO Finland
X-ray mammography
14.0
15.7
27
24
XX3DW
NOMESCO Finland
Time consuming IT work
14.0
15.7
27
24
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
169.1
14.8
15
*
N63
ICD-10 Finland
Unspecified lump in breast
12.7
14.0
25
24
D48.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Breast
26.0
13.3
18
8
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.3
12.4
60
223
WZC30
NOMESCO Finland
Teaching
7.3
12.0
30
52
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
11.6
11
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
11.6
11
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
11.7
11.0
20
20
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
59.8
9.8
11
*
HAB00
NOMESCO Finland
Excision of lesion of mammary gland
14.0
9.1
15
12
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
15.6
8.9
14
10
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
8.4
8
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
8.4
8
*
HAC15
NOMESCO Finland
Subcutaneous mastectomy with excision of mamilla
+∞
8.4
8
*
D24
ICD-10 Finland
Benign neoplasm of breast
10.4
7.5
14
15
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
85.0
7.5
8
*
XX1XN
NOMESCO Finland
Other isotope examination
+∞
7.4
7
*
WF002
NOMESCO Finland
Radical radiotherapy
+∞
7.4
7
*
N64.5
ICD-10 Finland
Other signs and symptoms in breast
10.2
7.0
13
14
HAA10
NOMESCO Finland
Biopsy of mammary gland
42.4
6.8
8
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
73.5
6.5
7
*
N60.8
ICD-10 Finland
Other benign mammary dysplasias
73.5
6.5
7
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
6.3
6
*
HAE00
NOMESCO Finland
Reconstruction of breast using prosthesis
+∞
6.3
6
*
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
+∞
6.3
6
*

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768793) Breast Pathology biopsy report
49
21
32.69
70.65
1.5
1.1
—
—
—
0
0
(4035726)
50
33
21.25
59.69
1.5
1.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
122
565
5.37
22.48
3.6
3.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
73
337
3.08
11.20
1.8
2.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
10
0
+∞
10.52
1.1
0.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
91
510
2.74
9.28
2.4
1.7
—
—
—
0
0
(3002256) Pathology report gross observation
35
118
3.49
8.84
1.5
1.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
57
257
2.85
8.79
1.9
1.9
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
104
643
2.65
8.42
5.4
3.3
umol/l
9.0
10.6
1.06
98
597
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
25
70
4.03
8.22
3.0
1.4
ug/l
2.0
2.9
1.39
17
56
(3003694) ABO and Rh group [Type] in Blood
63
322
2.54
7.39
1.2
1.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
106
723
2.29
6.08
7.2
5.9
e9/l
3.9
4.1
0.23
89
624
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
96
648
2.14
5.41
4.7
4.7
mmol/l
1.2
1.2
0.17
84
554
(3018418) pH of Serum or Plasma
62
384
1.98
4.14
3.8
3.1
ph
7.4
7.4
0.49
12
60
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
19
78
2.62
3.36
2.0
1.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
81
586
1.75
3.11
4.7
4.6
mmol/l
1.2
1.2
0.79
74
519
(40758558) Short blood count panel - Blood
47
289
1.87
3.10
4.6
4.5
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
76
542
1.74
3.05
4.7
3.2
g/l
37.0
36.4
0.36
70
507
(3019550) Sodium [Moles/volume] in Serum or Plasma
160
1469
3.47
3.05
14.2
12.2
mmol/l
139.9
139.9
0.03
160
1423
(3023103) Potassium [Moles/volume] in Serum or Plasma
160
1473
3.38
2.89
14.4
12.3
mmol/l
3.9
3.9
0.22
160
1424
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
14
5.17
2.76
1.3
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
15
4.82
2.62
1.3
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
15
4.82
2.62
1.3
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
16
4.52
2.50
1.6
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
16
4.52
2.50
1.6
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
16
4.52
2.50
1.6
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
9
28
3.34
2.34
1.2
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
28
161
1.89
2.23
2.0
1.9
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
7
19
3.80
2.17
1.4
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
22
118
2.00
2.14
2.3
1.9
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
21
112
2.00
2.07
2.0
1.8
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
61
451
1.56
1.94
2.1
1.9
mmol/l
2.4
2.4
1.28
52
381
(3033658) Prothrombin time (PT) actual/Normal
44
302
1.62
1.91
3.0
2.7
%
102.9
97.9
0.74
44
290
(3013512) EKG study
55
402
1.55
1.83
3.6
3.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
27
166
1.75
1.75
1.6
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
11
48
2.38
1.74
1.1
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
8
31
2.66
1.68
1.1
1.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
56
419
1.51
1.65
5.9
5.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
8
32
2.57
1.62
1.4
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
148
1362
1.80
1.56
12.3
9.5
ml/min/173m2
83.7
80.6
1.16
126
1081
(3019225) pH of Specimen
21
127
1.75
1.45
2.9
3.0
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
6
22
2.79
1.45
1.2
2.6
mmol/l
1.6
1.4
—
6
22
(3021589) Normoblasts [#/volume] in Blood
73
589
1.43
1.43
9.4
7.2
e9/l
0.0
0.0
0.84
64
479
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
10
46
2.25
1.43
1.0
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
23
2.67
1.38
1.0
1.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
17
3.00
1.37
1.0
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
17
3.00
1.37
1.4
1.2
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
83
691
1.40
1.34
6.0
5.2
e9/l
0.2
0.2
0.54
74
608
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
34
2.42
1.31
1.4
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
115
1019
1.42
1.26
3.6
3.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
42
313
1.46
1.24
1.4
1.6
mg/l
0.7
1.0
1.00
29
242
(3032080) INR in Blood by Coagulation assay
58
460
1.40
1.22
6.8
6.5
inr
1.2
1.2
0.15
15
141
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
28
192
1.55
1.22
4.1
4.4
%
32.5
33.5
0.18
22
117
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
19
118
1.69
1.21
1.7
3.2
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
11
57
2.00
1.20
1.0
1.3
—
2.3
—
0
13
(3000494) Fungus identified in Specimen by Culture
26
176
1.57
1.19
1.2
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
34
0.00
1.17
0.0
1.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
42
317
1.43
1.16
1.1
1.4
iu/ml
12.8
42.9
—
8
119
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
20
2.54
1.16
1.2
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
157
1495
1.92
1.15
13.7
10.1
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
78
658
1.35
1.10
6.3
4.7
e9/l
0.6
0.6
0.21
70
566
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
160
1537
2.13
1.10
11.5
8.4
u/l
24.6
23.3
0.44
160
1471
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
11
59
1.93
1.10
1.0
1.3
—
3.9
—
0
16
(3019198) Lymphocytes [#/volume] in Blood
80
679
1.34
1.08
6.1
4.7
e9/l
1.9
2.0
0.22
72
592
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
22
2.31
1.04
1.4
1.2
nmol/l
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
9
48
1.92
1.02
1.0
1.2
—
43.8
—
0
6
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
9
48
1.92
1.02
1.0
1.2
—
13.7
—
0
6
(3006315) Basophils [#/volume] in Blood
78
664
1.33
1.02
6.3
4.7
e9/l
0.0
0.0
0.18
70
567
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
0
29
0.00
0.98
0.0
1.1
—
2.2
—
0
15
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
5
23
2.21
0.98
1.2
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
13
77
1.75
0.98
1.2
1.5
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
11
64
1.77
0.88
1.0
1.2
—
1.0
—
0
5
(4010399)
6
115
0.50
0.86
1.8
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
147
1392
1.49
0.85
3.9
4.1
mmol/l
1.3
1.2
0.06
140
1272
(3019060) Gas panel - Arterial blood
11
65
1.74
0.84
2.0
6.8
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
20
139
1.50
0.84
1.4
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
6
32
1.91
0.82
1.3
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
0
24
0.00
0.80
0.0
1.8
—
4.9
—
0
24
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
24
0.00
0.80
0.0
1.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
24
0.00
0.80
0.0
1.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
0
24
0.00
0.80
0.0
2.6
—
61.9
—
0
24
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
25
0.00
0.79
0.0
1.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
29
372
0.73
0.77
4.8
3.8
estimate
0.0
0.0
—
9
122
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
44
359
1.31
0.75
1.6
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
24
2.12
0.75
1.4
1.2
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
5
24
2.12
0.75
1.0
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
13
84
1.59
0.74
1.4
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
155
1491
1.60
0.73
4.9
5.1
mmol/l
3.0
2.9
0.51
147
1375
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
25
2.03
0.73
1.2
1.9
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
9
57
1.61
0.72
1.6
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
7
40
1.78
0.72
1.7
3.9
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
153
1469
1.53
0.72
4.4
4.6
mmol/l
5.0
4.9
0.45
147
1358
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
5
26
1.95
0.71
1.4
1.2
nmol/l
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
5
27
1.88
0.69
1.4
1.9
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
9
138
0.63
0.64
1.0
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
11
162
0.66
0.62
1.6
1.6
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
30
1.69
0.62
1.4
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
20
0.00
0.61
0.0
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
20
0.00
0.61
0.0
1.6
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
26
327
0.76
0.60
1.5
1.5
nmol/l
23.4
23.8
0.03
20
284
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
1.7
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
22
0.00
0.60
0.0
1.0
—
—
—
0
0
(3015736) pH of Urine
64
562
1.23
0.59
3.4
3.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
60
526
1.22
0.56
2.7
2.9
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
105
973
1.22
0.55
4.5
4.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
37
439
0.80
0.55
1.8
1.6
mmol/l
1.4
1.4
0.18
37
373
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
9
62
1.48
0.54
1.4
1.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
118
1109
1.22
0.52
4.9
4.2
mm/h
11.3
11.6
0.09
112
1020
(3007566) Smooth muscle Ab [Titer] in Serum
6
40
1.52
0.52
1.2
1.1
—
80.0
—
0
5
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
151
1460
1.38
0.51
4.4
4.5
mmol/l
1.6
1.6
0.01
144
1350
(3000850) Epithelial cells [#/volume] in Urine
32
264
1.26
0.51
1.9
2.5
e6/l
6.8
7.5
0.12
26
235
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
31
255
1.27
0.50
3.3
3.6
ng/l
71.5
305.1
0.46
24
183
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
49
1.45
0.46
2.4
1.8
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
38
325
1.22
0.45
2.1
2.8
ng/l
303.7
1086.7
3.35
32
261
(3037522) Nuclear Ab [Titer] in Serum
27
222
1.26
0.44
1.4
1.4
titre
213.3
729.5
—
6
63
(3004716) Salmonella sp identified in Stool by Organism specific culture
6
92
0.64
0.43
1.2
1.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
28
334
0.81
0.43
1.9
2.0
umol/l
308.0
6074.3
1.60
21
286
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
5
33
1.53
0.41
1.2
2.1
ug/l
1.0
0.5
—
5
33
(3005033) Fetal Nuchal fold Thickness US
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
17
0.00
0.41
0.0
1.2
—
6.9
—
0
11
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
17
0.00
0.41
0.0
1.0
—
1.1
—
0
8
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
30
253
1.23
0.40
2.5
1.9
mmol/l
2.5
2.4
0.59
24
218
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
10
71
1.43
0.40
1.3
1.9
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
18
0.00
0.40
0.0
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
19
0.00
0.39
0.0
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
19
0.00
0.39
0.0
1.5
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
3.5
—
0.8
—
0
14
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
19
0.00
0.39
0.0
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
19
0.00
0.39
0.0
1.5
—
—
—
0
0
(1002224) Polysomnography panel
9
67
1.36
0.39
1.1
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
5
36
1.40
0.38
1.4
1.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
36
1.40
0.38
1.4
1.9
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
20
162
1.27
0.37
1.4
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
15
117
1.31
0.36
1.3
1.4
—
—
—
0
0
(3000492) Spirometry study
15
117
1.31
0.36
1.4
1.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
30
256
1.21
0.36
3.5
3.6
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
6
41
1.48
0.36
1.8
1.6
mu/l
375.8
308.7
—
6
36
(3022621) pH of Urine by Test strip
6
90
0.65
0.33
2.0
2.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
36
316
1.18
0.33
1.3
1.3
u/ml
6.1
11.8
0.46
14
133
(3026782) Osmolality of Urine
27
231
1.20
0.32
1.7
2.6
mosm/kgh2o
485.8
516.8
0.25
20
204
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
7
55
1.28
0.30
3.7
8.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
8
106
0.74
0.30
2.5
3.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
31
271
1.18
0.30
1.8
1.5
—
—
—
0
0
(3003338) MCHC [Mass/volume]
126
1217
1.15
0.28
16.8
13.9
g/l
331.4
330.8
0.30
126
1212
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
25
216
1.19
0.27
1.9
2.3
e6/l
1.1
1.2
0.04
14
115
(3000963) Hemoglobin [Mass/volume] in Blood
161
1588
1.46
0.26
20.8
15.7
g/l
133.8
133.5
0.13
161
1558
(3024731) MCV [Entitic volume]
161
1587
1.48
0.26
20.7
15.6
fl
90.8
90.8
0.06
161
1559
(3035941) MCH [Entitic mass]
161
1587
1.48
0.26
20.6
15.6
pg
30.1
30.1
0.07
161
1559
(40760892) CBC W Ordered Manual Differential panel - Blood
28
317
0.86
0.26
4.2
3.7
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
41
371
1.14
0.26
2.4
3.0
e6/l
14.5
64.5
1.52
31
281
(36304419) Bacteria [Presence] in Urine
38
342
1.14
0.26
2.4
2.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
26
295
0.86
0.25
1.9
1.3
g/l
1.8
2.4
—
10
180
(3000991) Gas panel - Venous blood
10
78
1.30
0.25
4.1
6.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
50
461
1.12
0.24
3.1
3.5
e6/l
106.3
77.5
0.12
32
311
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
20
172
1.19
0.23
1.8
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
15
125
1.22
0.23
1.9
1.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
22
191
1.18
0.23
1.9
2.6
e6/l
2.1
4.0
0.76
11
91
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
5
40
1.26
0.22
1.8
1.3
g/l
0.0
0.0
—
5
40
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
5
40
1.26
0.22
1.8
1.4
g/l
0.0
0.1
—
5
40
(3002385) Erythrocyte distribution width [Ratio]
122
1183
1.12
0.22
17.8
12.9
%
13.5
13.6
0.48
122
1159
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
15
126
1.21
0.22
1.9
1.6
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
11
0.00
0.21
0.0
1.3
—
158.2
—
0
11
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
10
0.00
0.21
0.0
4.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
10
0.00
0.21
0.0
1.8
—
10.8
—
0
10
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
37
337
1.13
0.21
4.2
3.3
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
0.6
—
0
12
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
24
212
1.15
0.21
1.3
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
88
918
0.91
0.20
3.2
2.9
—
—
—
0
0
(4027681)
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
0
14
0.00
0.20
0.0
2.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
38
348
1.12
0.20
2.4
2.8
e6/l
0.1
0.4
1.39
28
255
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
17
196
0.85
0.20
6.0
4.8
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
141
1382
1.13
0.18
5.6
5.5
mmol/mol
39.2
39.3
0.08
132
1291
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
7
60
1.17
0.18
1.3
1.6
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
7
62
1.13
0.17
1.1
2.3
u/l
31.4
41.8
—
7
55
(3045414) Leukocytes [Presence] in Urine
5
68
0.73
0.17
1.2
1.7
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
47
440
1.10
0.17
2.6
2.9
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
69
658
1.08
0.16
2.6
2.2
nmol/l
80.8
80.3
0.06
61
588
(3009542) Hematocrit [Volume Fraction] of Blood
132
1293
1.10
0.15
15.0
11.5
%
37.9
39.8
1.21
100
938
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
11
93
1.20
0.15
3.2
2.0
g/l
0.2
0.2
0.67
11
84
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
10
84
1.20
0.14
1.1
1.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
44
414
1.09
0.14
3.0
3.1
mg/l
13.5
377.4
0.85
29
242
(3041096) Erythrocytes [Presence] in Urine by Automated
37
395
0.92
0.13
2.4
3.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
53
557
0.93
0.13
3.5
3.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
74
717
1.06
0.10
3.5
3.5
estimate
0.0
0.0
—
9
117
(3009508) Creatinine [Moles/volume] in Urine
46
439
1.07
0.10
2.7
3.0
mmol/l
6.2
6.8
0.52
41
362
(4094501)
5
43
1.17
0.10
1.0
1.0
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
5
44
1.14
0.10
1.4
3.2
%
33.7
46.1
—
5
44
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
57
1.05
0.08
2.3
1.3
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
7
66
1.06
0.08
9.0
5.5
mmol/l
23.2
25.6
—
7
66
(3007853) Bacteria identified in Skin by Aerobe culture
14
127
1.11
0.08
2.2
1.6
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
12
133
0.89
0.08
1.3
1.2
iu/ml
152.0
139.3
—
6
60
(3036481) Cortisol [Moles/volume] in Serum or Plasma
13
143
0.90
0.07
1.7
2.0
nmol/l
310.9
362.1
0.56
13
137
(3025941) Bacteria identified in Stool by Culture
8
78
1.03
0.07
1.8
1.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
140
1414
0.94
0.07
13.3
10.3
mg/l
15.5
19.7
1.46
119
1036
(3020682) Albumin/Creatinine [Ratio] in Urine
45
435
1.05
0.06
3.2
3.8
mg/mmol
5.5
5.2
0.02
29
247
(3035350) Ketones [Presence] in Urine by Test strip
73
715
1.04
0.05
3.5
3.5
estimate
0.0
0.0
—
8
122
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
33
317
1.05
0.05
2.4
2.2
mg/l
2.2
3.1
2.24
27
266
(3026008) Bacteria identified in Urine by Culture
45
437
1.04
0.05
2.4
2.8
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
35
338
1.04
0.04
4.0
3.7
kg/l
1.0
1.0
—
5
51
(3012544) pH of Venous blood
11
101
1.10
0.04
1.0
3.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
12
111
1.09
0.04
1.3
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
12
111
1.09
0.04
3.0
2.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
35
361
0.96
0.04
1.5
1.3
u/ml
0.5
2.6
—
9
112
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
59
581
1.02
0.02
2.2
1.9
pmol/l
100.7
99.8
0.05
30
266
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
48
488
0.98
0.01
2.7
3.2
ng/l
10.5
20.0
4.39
29
305
(46235355) HIV 1 and 2 tests - Meaningful Use set
20
193
1.04
0.01
2.4
1.7
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
146
1453
1.04
0.01
4.7
4.5
mmol/l
5.9
5.8
0.34
136
1339
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
123
1223
1.02
0.01
6.0
4.3
pmol/l
14.7
14.6
0.20
115
1132
(3019309) Folate [Moles/volume] in Red Blood Cells
24
246
0.97
0.00
2.3
1.6
nmol/l
980.4
1269.3
0.90
17
183
(3017732) Neutrophils [#/volume] in Blood
10
99
1.01
0.00
1.3
2.3
e9/l
4.6
3.8
—
10
75
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
10
101
0.99
0.00
2.0
3.2
u/l
214.7
247.9
—
10
95
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
10
101
0.99
0.00
1.1
2.7
ng/l
51.6
157.3
—
10
92
(3020630) Protein [Mass/volume] in Serum or Plasma
10
101
0.99
0.00
1.4
1.5
g/l
67.6
68.2
—
10
96
(36660697) Celiac disease serology panel - Serum
12
119
1.01
0.00
1.6
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
12
119
1.01
0.00
1.2
1.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
71
713
0.99
0.00
5.0
4.8
estimate
0.0
0.0
—
8
118
(3002032) Base excess in Venous blood by calculation
10
95
1.06
0.00
1.0
3.4
mmol/l
4.3
2.4
—
10
81
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.1
—
6.5
—
0
7
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
120.5
—
0
9
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
1987.0
—
0
7
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
5
50
1.00
0.00
1.6
1.3
pmol/l
44.4
66.4
—
5
50
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
208.4
—
0
5
(3015183) Erythrocyte sedimentation rate
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
53
0.94
0.00
1.8
1.3
g/l
3.5
4.0
—
5
42
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
51
0.98
0.00
1.8
1.3
g/l
7.9
11.0
—
5
46
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
15
150
1.00
0.00
1.5
1.7
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
7
70
1.00
0.00
1.6
2.6
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
295.5
—
0
5
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
8
0.00
0.00
0.0
1.0
—
5.6
—
0
8
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(4034850)
6
59
1.02
0.00
1.7
6.3
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
6
69
0.86
0.00
1.0
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
6
69
0.86
0.00
2.5
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
5
49
1.02
0.00
1.0
4.0
mmol/l
28.4
24.8
—
5
43
(3004588) Protein electrophoresis panel - Serum or Plasma
8
89
0.89
0.00
1.5
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
50
1.00
0.00
1.8
1.3
g/l
2.4
3.2
—
5
43
(3036071) Salmonella sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
53
0.94
0.00
1.8
1.3
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
12.1
—
0
6
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
18.0
—
0
5
(3017704) Immunofixation for Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
30.1
—
0
8
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
53
0.94
0.00
1.8
1.3
g/l
6.9
7.9
—
5
43
(4198724)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_INSITU_BREAST_EXALLC and mortality.

Females

Parameter HR [95% CI] p-value
CD2_INSITU_BREAST_EXALLC 0.892 [0.79, 1.01] 0.068
Birth year 0.995 [0.99, 1.0] 0.206

During the follow-up period (1.1.1998 — 31.12.2019), 553 out of 5965 females with CD2_INSITU_BREAST_EXALLC died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have CD2_INSITU_BREAST_EXALLC.

N-year risk Females Males
1 0.074% No data
5 0.47% No data
10 1.217% No data
15 2.416% No data
20 4.331% No data

Relationships between endpoints

↥

Index endpoint: CD2_INSITU_BREAST_EXALLC – Carcinoma in situ of breast

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data